Yesterday, Pivotal Acquisition Corp. (PVT), announced that it had entered into a commitment letter with MGG Investment Group, LP (“MGG”), where Pivotal may borrow up to $150 million of 5-year convertible notes, thus providing a backstop to their business combination with KLDiscovery. However, there seemed to be some confusion as to just “how much” they’re backstopping.
If you looked at the proxy that was filed the same day, there was language within it that implied the $150 million convertible note was IN ADDITION to the $50 million forward purchase agreement (also with MGG), which would have provided for up to $200 million of backstop, less transaction expenses of ~$19 million. For instance:
“(b) the term “Available Closing Date Cash” means, as of immediately prior to the Closing, an aggregate amount equal to the result of (without duplication): (i) the cash available to be released from the Trust Account and the aggregate net cash proceeds actually received from any investment in Parent approved after the date hereof pursuant to Section 4.1(f), including up to $50,000,000 pursuant to the Forward Purchase Contract (if any), minus (ii) the aggregate amount of all redemptions of Parent Common Stock by any Redeeming Stockholders; minus (iii) the Outstanding Parent Expenses, minus (iv) to the extent not included in the Outstanding Parent Expenses, the sum of all outstanding deferred, unpaid or contingent underwriting, broker’s or similar fees, commissions or expenses owed by Parent or any other party to the extent Parent or any of its Subsidiaries is responsible for or obligated to reimburse or repay any such amounts, minus (v) the aggregate amount outstanding under all indebtedness for borrowed money of Parent or Merger Sub (including any Parent Borrowings);”
However, it has now been suggested (on good authority) that the new $150 million convertible note should be considered “in lieu” of the $50 million forward purchase and the language was just a hold over from a previous filing. As a result, Pivotal would need $25 million to remain in trust in order to satisfy the $175 million available cash at closing condition ($175M – $150M = $25M). That’s not “fully backstopped”, but it’s still a pretty good backstop for a $233 million SPAC.
However, there’s still an itch that needs to be scratched – are the transaction expenses to be included or excluded? There seems to be a consensus among the SPAC community that it’s not included and Pivotal only need $25 million in trust post-vote. Maybe we’ll get a revised proxy where they clean up the language so we can all have final clarity. Additionally, maybe they left in the $50 million Forward Purchase Agreement language in case they need to use it (in a worst case scenario where redemptions leave less than $25 million remaining in trust).
For now, everyone is working with the $25 million cash left in trust post-redemptions figure. If that changes, an update will be provided.


D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...